LIPT2 and invasive breast carcinoma: As shown in Fig. 5, in most cancers, LIPT2 expression was negatively linked to cancer-associated fibroblasts (CAFs) infiltration levels, especially in Breast invasive carcinoma (BRCA), LUAD, and Stomach adenocarcinoma (STAD), while it was positively correlated with B-cell infiltration values, such as BLCA, BRCA, Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC), KICH.